2q37 deletion syndrome is a condition that can affect many parts of the body. Most babies with 2q37 deletion syndrome are born with weak muscle tone (hypotonia), which usually improves with age. Other neurological abnormalities that are common in affected individuals include mild to severe intellectual disability; delayed development of motor skills, such as sitting and walking; and behavioral problems. About 25 percent of people with this condition have autism spectrum disorder, a developmental condition that affects communication and social interaction.
2q37 deletion syndrome is caused by deletions of genetic material from a specific region in the long (q) arm of chromosome 2. The deletions occur near the end of the chromosome at a location designated 2q37. The size of the deletion varies among affected individuals, with most affected people missing 2 million to 9 million DNA building blocks (also written as 2 Mb to 9 Mb).
2q37 deletion syndrome appears to be a rare condition, although its exact prevalence is unknown. At least 115 cases have been reported worldwide.
Most cases of 2q37 deletion syndrome are not inherited. They result from a chromosomal deletion that occurs as a random event during the formation of reproductive cells (eggs or sperm) or in early fetal development. Affected people typically have no history of the disorder in their family.
Paulo Otto practices in Sao Paulo, Brazil. Otto is rated as a Distinguished expert by MediFind in the treatment of 2q37 Deletion Syndrome. He is also highly rated in 5 other conditions, according to our data. His top areas of expertise are 2q37 Deletion Syndrome, Brachydactyly, Genital Dwarfism, and Robinow Syndrome.
Eric Lancaster is a Neurologist in Philadelphia, Pennsylvania. Lancaster has been practicing medicine for over 20 years and is rated as an Advanced expert by MediFind in the treatment of 2q37 Deletion Syndrome. He is also highly rated in 91 other conditions, according to our data. His top areas of expertise are Encephalitis, Anti-NMDA Receptor Encephalitis, Rasmussen Encephalitis, and Paraneoplastic Cerebellar Degeneration. Lancaster is currently accepting new patients.
Michael Keefe is a Hematologist Oncology specialist and a Hematologist in Milwaukee, Wisconsin. Keefe has been practicing medicine for over 24 years and is rated as an Advanced expert by MediFind in the treatment of 2q37 Deletion Syndrome. He is also highly rated in 107 other conditions, according to our data. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Unicentric Castleman Disease (UCD), and Castleman Disease. Keefe is currently accepting new patients.
Published Date: October 01, 2018Published By: National Institutes of Health
There is no recent research available for this condition. Please check back because thousands of new papers are published every week and we strive to find and display the most recent relevant research as soon as it is available.